Ferrer Pomares Pierre, Duque Santana Pablo, Moreno Mateo Fernando, Mengis Palleck Charles L, Tomé Bermejo Felix, Álvarez Galovich Luis
Spinal Conditions Unit, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
Department of Orthopaedic and Trauma Surgery, General University Hospital of Villalba, Madrid, Spain.
Global Spine J. 2025 May;15(4):1890-1894. doi: 10.1177/21925682241270097. Epub 2024 Aug 1.
Study DesignObservational Study.ObjectivesSurgical site infections (SSIs) are one of the major complications in spine surgery. Numerous factors that increase the risk of SSI have been widely described. However, clinical guidelines on antibiotic prophylaxis are usually common for all patients. There are no specific guidelines for patients with a high risk of infection. The aim of this paper is to create a specific protocol for patients at high risk of SSI.MethodsThis is a three-cohort study using a prospective database. Risk patients are those who meet at least two of the following criteria: obesity, diabetes, reoperation and immunosuppression. Between October 2021 and April 2023, 132 patients were recruited.They were divided into three cohorts: cohort A, 46 patients, standard prophylaxis with cefazolin 2 g/8 h for 24 h; cohort B, 46 patients, cefazolin 2 g/8h and amikacin 500 mg/12 h for 24 h; cohort C, 40 patients, cefazolin 2 g/8h and amikacin 500 mg/12 h for 72 h.ResultsThere was a significant decrease in the infection rate depending on the prophylaxis (23.9% in cohort A, 8.7% in cohort B, and 2.5% in cohort C). When logistic regression models were applied and cohorts B and C were compared with A, the following results were obtained: OR of 0.30 (CI: 0.08 - 0.97; = 0.057) and 0.08 (IC: 0.00 - 0.45; = 0.019), respectively.ConclusionsProphylaxis with prolonged double antibiotic therapy with cefazolin and amikacin is associated with a statistically significant decrease in the rate of SSI in patients with a high risk of infection.
研究设计
观察性研究。
目的
手术部位感染(SSIs)是脊柱手术中的主要并发症之一。众多增加手术部位感染风险的因素已被广泛描述。然而,抗生素预防的临床指南通常对所有患者都是通用的。对于感染风险高的患者没有具体的指南。本文的目的是为手术部位感染高风险患者制定一个特定的方案。
方法
这是一项使用前瞻性数据库的三队列研究。风险患者是那些至少符合以下两项标准的患者:肥胖、糖尿病、再次手术和免疫抑制。在2021年10月至2023年4月期间,招募了132名患者。他们被分为三个队列:队列A,46名患者,用头孢唑林2g/8小时,共24小时进行标准预防;队列B,46名患者,头孢唑林2g/8小时和阿米卡星500mg/12小时,共24小时;队列C,40名患者,头孢唑林2g/8小时和阿米卡星500mg/12小时,共72小时。
结果
根据预防措施的不同,感染率有显著下降(队列A为23.9%,队列B为8.7%,队列C为2.5%)。当应用逻辑回归模型并将队列B和C与A进行比较时,得到以下结果:比值比分别为0.30(95%置信区间:0.08 - 0.97;P = 0.057)和0.08(95%置信区间:0.00 - 0.45;P = 0.019)。
结论
使用头孢唑林和阿米卡星进行延长的双重抗生素治疗预防与感染高风险患者的手术部位感染率在统计学上有显著降低相关。